|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 83.45 USD | -3.63% |
|
-4.16% | -14.22% |
| 07-31 | IRADIMED CORPORATION Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-31 | IRADIMED CORPORATION, Q2 2026 Earnings Call, Jul 31, 2026 |
Company Valuation: IRADIMED CORPORATION
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,067 | - | - |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -13.77% | - | - |
| Enterprise Value (EV) | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,067 | 1,067 | 1,067 |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -13.77% | 0% | 0% |
| P/E | 62.4x | 27.7x | 35.2x | 36.7x | 55.6x | 43.5x | 37.6x | 33.4x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.7x | 1.1x | 3.3x | 3.3x | 4.48x | 2.4x | 2.6x |
| Capitalization / Revenue | 13.6x | 6.67x | 9.13x | 9.52x | 14.8x | 11.7x | 10.6x | 9.46x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 11.7x | 10.6x | 9.46x |
| EV / EBITDA | - | - | - | - | - | 33.7x | 31x | 27.3x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 35.3x | 31.5x | 28.7x |
| EV / FCF | - | - | - | - | - | 59.9x | 49.6x | 60.3x |
| FCF Yield | - | - | - | - | - | 1.67% | 2.01% | 1.66% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.74 | 1.02 | 1.35 | 1.5 | 1.75 | 1.92 | 2.22 | 2.5 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 41.81 | 53.3 | 65.56 | 73.24 | 83.81 | 91.2 | 101 | 112.8 |
| EBITDA 1 | - | - | - | - | - | 31.7 | 34.4 | 39.1 |
| EBIT 1 | 9.818 | 15.63 | 20.04 | 21.96 | 26.15 | 30.2 | 33.85 | 37.2 |
| Net income 1 | 9.325 | 12.83 | 17.19 | 19.23 | 22.48 | 24.65 | 28.45 | 32 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 46.21 | 28.29 | 47.47 | 55.00 | 97.28 | 83.45 | 83.45 | 83.45 |
| Nbr of stocks (in thousands) | 12,342 | 12,566 | 12,606 | 12,673 | 12,721 | 12,787 | - | - |
| Announcement Date | 04/02/22 | 02/02/23 | 08/02/24 | 13/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 45.1x | - | - | - | 1.07B | |
| 40.14x | 4.89x | 26.96x | 0.33% | 13.22B | |
| 34.37x | 8.64x | 25.77x | 1.27% | 4.23B | |
| 29.37x | 2.73x | 22.07x | 1.17% | 1.27B | |
| -10.7x | - | - | - | 300M | |
| Average | 27.66x | 5.42x | 24.94x | 0.92% | 4.02B | |
| Weighted average by Cap. | 37.75x | 5.59x | 26.36x | 0.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRMD Stock
- Valuation IRADIMED CORPORATION
Select your edition
All financial news and data tailored to specific country editions
